Literature DB >> 22704516

Il2rg gene-targeted severe combined immunodeficiency pigs.

Shunichi Suzuki1, Masaki Iwamoto2, Yoriko Saito3, Daiichiro Fuchimoto1, Shoichiro Sembon1, Misae Suzuki1, Satoshi Mikawa4, Michiko Hashimoto2, Yuki Aoki3, Yuho Najima3, Shinsuke Takagi3, Nahoko Suzuki3, Emi Suzuki5, Masanori Kubo6, Jun Mimuro7, Yuji Kashiwakura7, Seiji Madoiwa7, Yoichi Sakata7, Anthony C F Perry8, Fumihiko Ishikawa9, Akira Onishi10.   

Abstract

A porcine model of severe combined immunodeficiency (SCID) promises to facilitate human cancer studies, the humanization of tissue for xenotransplantation, and the evaluation of stem cells for clinical therapy, but SCID pigs have not been described. We report here the generation and preliminary evaluation of a porcine SCID model. Fibroblasts containing a targeted disruption of the X-linked interleukin-2 receptor gamma chain gene, Il2rg, were used as donors to generate cloned pigs by serial nuclear transfer. Germline transmission of the Il2rg deletion produced healthy Il2rg(+/-) females, while Il2rg(-/Y) males were athymic and exhibited markedly impaired immunoglobulin and T and NK cell production, robustly recapitulating human SCID. Following allogeneic bone marrow transplantation, donor cells stably integrated in Il2rg(-/Y) heterozygotes and reconstituted the Il2rg(-/Y) lymphoid lineage. The SCID pigs described here represent a step toward the comprehensive evaluation of preclinical cellular regenerative strategies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22704516     DOI: 10.1016/j.stem.2012.04.021

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  68 in total

Review 1.  Genetically engineered livestock for biomedical models.

Authors:  Christopher S Rogers
Journal:  Transgenic Res       Date:  2016-01-28       Impact factor: 2.788

Review 2.  Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.

Authors:  Jing Yao; Jiaojiao Huang; Jianguo Zhao
Journal:  Hum Genet       Date:  2016-07-18       Impact factor: 4.132

Review 3.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 4.  Livestock models for exploiting the promise of pluripotent stem cells.

Authors:  R Michael Roberts; Ye Yuan; Nicholas Genovese; Toshihiko Ezashi
Journal:  ILAR J       Date:  2015

5.  Pigs with Severe Combined Immunodeficiency Are Impaired in Controlling Influenza A Virus Infection.

Authors:  Daniela S Rajao; Crystal L Loving; Emily H Waide; Phillip C Gauger; Jack C M Dekkers; Christopher K Tuggle; Amy L Vincent
Journal:  J Innate Immun       Date:  2016-12-17       Impact factor: 7.349

6.  Key Immune Cell Cytokines Affects the Telomere Activity of Cord Blood Cells In vitro.

Authors:  Balal Brazvan; Raheleh Farahzadi; Seyede Momeneh Mohammadi; Soheila Montazer Saheb; Dariush Shanehbandi; Laurent Schmied; Jafar Soleimani Rad; Masoud Darabi; Hojjatollah Nozad Charoudeh
Journal:  Adv Pharm Bull       Date:  2016-06-30

7.  Direct introduction of gene constructs into the pronucleus-like structure of cloned embryos: a new strategy for the generation of genetically modified pigs.

Authors:  Mayuko Kurome; Simon Leuchs; Barbara Kessler; Elisabeth Kemter; Eva-Maria Jemiller; Beatrix Foerster; Nikolai Klymiuk; Valeri Zakhartchenko; Eckhard Wolf
Journal:  Transgenic Res       Date:  2016-12-10       Impact factor: 2.788

8.  Strategies for improving animal models for regenerative medicine.

Authors:  Jose Cibelli; Marina E Emborg; Darwin J Prockop; Michael Roberts; Gerald Schatten; Mahendra Rao; John Harding; Oleg Mirochnitchenko
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

9.  Not All SCID Pigs Are Created Equally: Two Independent Mutations in the Artemis Gene Cause SCID in Pigs.

Authors:  Emily H Waide; Jack C M Dekkers; Jason W Ross; Raymond R R Rowland; Carol R Wyatt; Catherine L Ewen; Alyssa B Evans; Dinesh M Thekkoot; Nicholas J Boddicker; Nick V L Serão; N Matthew Ellinwood; Christopher K Tuggle
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

Review 10.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.